IRIS Accounts Production v23.1.0.753 08529337 director 1.6.22 31.5.23 31.5.23 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure085293372022-05-31085293372023-05-31085293372022-06-012023-05-31085293372021-05-31085293372021-06-012022-05-31085293372022-05-3108529337ns16:EnglandWales2022-06-012023-05-3108529337ns15:PoundSterling2022-06-012023-05-3108529337ns11:Director12022-06-012023-05-3108529337ns11:PrivateLimitedCompanyLtd2022-06-012023-05-3108529337ns11:SmallEntities2022-06-012023-05-3108529337ns11:AuditExempt-NoAccountantsReport2022-06-012023-05-3108529337ns11:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3108529337ns11:SmallCompaniesRegimeForAccounts2022-06-012023-05-3108529337ns11:FullAccounts2022-06-012023-05-3108529337ns11:RegisteredOffice2022-06-012023-05-3108529337ns6:CurrentFinancialInstruments2023-05-3108529337ns6:CurrentFinancialInstruments2022-05-3108529337ns6:ShareCapital2023-05-3108529337ns6:ShareCapital2022-05-3108529337ns6:RevaluationReserve2023-05-3108529337ns6:RevaluationReserve2022-05-3108529337ns6:RetainedEarningsAccumulatedLosses2023-05-3108529337ns6:RetainedEarningsAccumulatedLosses2022-05-3108529337ns6:ComputerEquipment2022-06-012023-05-3108529337ns6:ComputerEquipment2022-05-3108529337ns6:ComputerEquipment2023-05-3108529337ns6:ComputerEquipment2022-05-3108529337ns6:CostValuationns6:ListedExchangeTraded2022-05-3108529337ns6:AdditionsToInvestmentsns6:ListedExchangeTraded2023-05-3108529337ns6:RevaluationsIncreaseDecreaseInInvestmentsns6:ListedExchangeTraded2023-05-3108529337ns6:CostValuationns6:ListedExchangeTraded2023-05-3108529337ns6:ListedExchangeTraded2023-05-3108529337ns6:ListedExchangeTraded2022-05-3108529337ns6:WithinOneYearns6:CurrentFinancialInstruments2023-05-3108529337ns6:WithinOneYearns6:CurrentFinancialInstruments2022-05-3108529337ns6:AfterOneYearns6:Non-currentFinancialInstruments2023-05-3108529337ns6:AfterOneYearns6:Non-currentFinancialInstruments2022-05-3108529337ns6:WithinOneYear2023-05-3108529337ns6:WithinOneYear2022-05-3108529337ns6:RevaluationReserve2022-05-3108529337ns11:Director112022-05-3108529337ns11:Director112021-05-3108529337ns11:Director112022-06-012023-05-3108529337ns11:Director112021-06-012022-05-3108529337ns11:Director112023-05-3108529337ns11:Director112022-05-31
REGISTERED NUMBER: 08529337 (England and Wales)















Financial Statements for the Year Ended 31 May 2023

for

Connaught Healthcare Limited

Connaught Healthcare Limited (Registered number: 08529337)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Connaught Healthcare Limited

Company Information
for the Year Ended 31 May 2023







DIRECTOR: Dr P A Shah





REGISTERED OFFICE: 22 JFK House
Royal Connaught Park
Bushey
Watford
Hertfordshire
WD23 2RA





REGISTERED NUMBER: 08529337 (England and Wales)





ACCOUNTANTS: Richard Smedley Limited
Chartered Accountants & Registered Auditors
Richmond House
Lawnswood Business Park
Redvers Close
Leeds
West Yorkshire
LS16 6QY

Connaught Healthcare Limited (Registered number: 08529337)

Balance Sheet
31 May 2023

31.5.23 31.5.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 74 147
Investments 5 330,000 275,906
330,074 276,053

CURRENT ASSETS
Debtors 6 181,096 121,149
Cash at bank 528,688 322,059
709,784 443,208
CREDITORS
Amounts falling due within one year 7 159,349 95,951
NET CURRENT ASSETS 550,435 347,257
TOTAL ASSETS LESS CURRENT
LIABILITIES

880,509

623,310

PROVISIONS FOR LIABILITIES 6,640 7,288
NET ASSETS 873,869 616,022

CAPITAL AND RESERVES
Called up share capital 100 100
Fair value reserve 9 31,888 38,618
Retained earnings 841,881 577,304
SHAREHOLDERS' FUNDS 873,869 616,022

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Connaught Healthcare Limited (Registered number: 08529337)

Balance Sheet - continued
31 May 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 January 2024 and were signed by:





Dr P A Shah - Director


Connaught Healthcare Limited (Registered number: 08529337)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. STATUTORY INFORMATION

Connaught Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents net invoiced sales of services. Revenue is recognised when the company obtains the right to receive consideration for services provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - Straight line over 3 years

Financial instruments
Basic financial instruments are recognised at amortised cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 2 ).

Connaught Healthcare Limited (Registered number: 08529337)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 June 2022
and 31 May 2023 2,961
DEPRECIATION
At 1 June 2022 2,814
Charge for year 73
At 31 May 2023 2,887
NET BOOK VALUE
At 31 May 2023 74
At 31 May 2022 147

5. FIXED ASSET INVESTMENTS
Listed
investments
£   
COST OR VALUATION
At 1 June 2022 275,906
Additions 60,001
Revaluations (5,907 )
At 31 May 2023 330,000
NET BOOK VALUE
At 31 May 2023 330,000
At 31 May 2022 275,906

Cost or valuation at 31 May 2023 is represented by:

Listed
investments
£   
Valuation in 2016 1,192
Valuation in 2017 10,950
Valuation in 2018 2,370
Valuation in 2019 1,035
Valuation in 2020 (24,298 )
Valuation in 2021 53,269
Valuation in 2022 1,388
Valuation in 2023 (5,906 )
Cost 290,000
330,000

Connaught Healthcare Limited (Registered number: 08529337)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

5. FIXED ASSET INVESTMENTS - continued

Listed and unlisted Investment are included at fair value.

6. DEBTORS
31.5.23 31.5.22
£    £   
Amounts falling due within one year:
Other debtors 148,735 102,365

Amounts falling due after more than one year:
Other debtors 32,361 18,784

Aggregate amounts 181,096 121,149

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Trade creditors 164 104
Taxation and social security 119,665 91,572
Other creditors 39,520 4,275
159,349 95,951

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.5.23 31.5.22
£    £   
Within one year 2,181 7,700

9. RESERVES
Fair
value
reserve
£   
At 1 June 2022 38,618
Fixed asset invest revaluation (6,730 )

At 31 May 2023 31,888

Connaught Healthcare Limited (Registered number: 08529337)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2023 and 31 May 2022:

31.5.23 31.5.22
£    £   
Dr P A Shah
Balance outstanding at start of year 57,002 36,319
Amounts advanced 131,101 20,683
Amounts repaid (90,873 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 97,230 57,002

Interest is charged on the loans at the official rate. The loans are repayable on demand.